SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-326233
Filing Date
2021-11-10
Accepted
2021-11-10 17:24:06
Documents
18
Period of Report
2021-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d255799d8k.htm   iXBRL 8-K 34223
2 EX-1.1 d255799dex11.htm EX-1.1 186102
3 EX-4.1 d255799dex41.htm EX-4.1 59410
4 EX-5.1 d255799dex51.htm EX-5.1 16018
5 EX-99.1 d255799dex991.htm EX-99.1 8926
9 GRAPHIC g255799g1109223138437.jpg GRAPHIC 4975
10 GRAPHIC g255799g1111002211905.jpg GRAPHIC 5300
  Complete submission text file 0001193125-21-326233.txt   524409

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kdny-20211109.xsd EX-101.SCH 2895
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20211109_lab.xml EX-101.LAB 18139
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20211109_pre.xml EX-101.PRE 11410
11 EXTRACTED XBRL INSTANCE DOCUMENT d255799d8k_htm.xml XML 3364
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 211397935
SIC: 2834 Pharmaceutical Preparations